Mylan has rejected a $40bn takeover bid from Israel's Teva, a generic drugs rival double its size, and confirmed its pursuit of cough remedies maker Perrigo in the latest stage of the three-way takeover battle on Monday.
The nations' largest airlines last week reported ridiculous - for them - first quarter profits. And it had far less to do with the price of oil and jet fuel than you've probably read.
(Reuters) - U.S. stocks reversed course to move lower in early afternoon trading on Monday as healthcare stocks led by Amgen (AMGN.
NEW YORK - Nelson Peltz gained a powerful backer Monday after the proxy advisory firm Institutional Shareholder Services said that change may be warranted at DuPont and recommended shareholders give the billionaire investor seats on its board.
NEW YORK - U.S. stocks edged lower Monday afternoon as investors waited for a busy week of corporate earnings to begin. European shares rallied on the hopes that Greece will strike a deal with its creditors for new bailout money after it reshuffled its ...